There exists considerable variation in patient’s response to gonadotropin stimulation when undergoing assisted reproductive technologies (ARTs). Serum anti-Müllerian hormone (AMH) level has been shown to be a robust predictor of ovarian response and is used to guide gonadotropin dosing.